M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)

Condition:   Carcinoma, Non-Small-Cell Lung Interventions:   Drug: Cisplatin;   Drug: Carboplatin;   Drug: Pemetrexed;   Drug: Nab-paclitaxel;   Drug: Gemcitabine;   Drug: Docetaxel;   Drug: M7824 Sponsors:   EMD Serono Research & Development Institute, Inc.;   Merck KGaA, Darmstadt, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials